RE:RE:RE:RE:Willow's FutureSo I can give the answer CEO Trevor would give. Willow can produce CBG significantly cheaper and with greater purity. And in much less time. And with much less impact on the environment. So that Willow will be the last one going belly up. Also pharmaceutical companies need consistent purity of supply. This is something that is very hard by extracting from the plant what little bit grows inside it. So what is going to happen as more and more become educated is that their will be a greater demand for biosynthetically produced CBG over conventional plant production at least among pharmaceutical companies and the food industry. And this will increase Willow's margins. So then the issue isn't that their are too many suppliers . Because Willow produces the highest purity with the greatest consistency, it's product will be the most in demand . The real issue with such a brand new market is the research going in to find health benefits to all these different molecules. For example I know many friends that regularly use prescription sleeping pills but they can be addictive. But if CBN can be proven to help one's sleep and without the strong addiction, it would be an enormous market the world over. So we need the research people to find real proven health benefits to all these extremely rare molecules. Then Willow's success is assured